The session today shows a wave of recovery after the declines that have been ongoing since Thursday. US indices are gaining around 3% in the first hour of trading (US500 is up 3.01%, US100 3.26%, and US30 is up 2.7%).
Although yesterday's US indices were close to a technical bear market (in the initial phase of the session, US indices were trading at levels exceeding a 20% drop from recent peaks), investors are still far from the typical bear market sentiment. Usually, in such a situation, investors ignore good news and act more aggressively in the event of negative information. However, today's start of the US session indicates that investor sentiment is dominated by hope, and the markets are looking for a basis for rebounding from the declines that have been ongoing since Thursday.
Given the incoming rumors about potential international agreements and progress in negotiations, quotations (especially of technology companies) are recording clear rebounds. At the same time, however, China still maintains its “fight to the finish” stance, although it seems that the market is more willing to look towards the scenario outlined by Scott Bessent (Treasury Secretary), who believes that the US can emerge from the whole customs mess “with good deals”.
BigTechs lead today’s gains. Source: xStation
The US100 contract is currently testing the resistance set by the 200-period EMA (golden curve on the chart) on the M30 interval. Yesterday, this level was the main barrier for the demand side. Source: xStation
Daily Summary: U.S. stock indices are climbing following the PPI data
US OPEN: Wall Street Rallies on Soft PPI Data
BREAKING: US PPI comes in weaker than expected. EURUSD gains ground
JP Morgan earnings: Good, but it could have been better
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
